Year in Review: Physicians Pick the Biggest News of 2019
Check out TCTMD’s interactive feature exploring the biggest news impacting cardiology this year, chosen by experts across subspecialties.
Concerns about paclitaxel-based devices in peripheral vascular disease, a diabetes drug repurposed for heart failure, TAVR devices in patients at low risk for surgery, the long-awaited ISCHEMIA trial results, and the best approach for treating left main coronary disease—the same big themes were mentioned in the multiple interviews TCTMD reporters did to wrap up the year. Top cardiologists from around the globe weighed in to tell us about the studies, approvals, and controversies that had an impact on their practice in 2019.
Click on our interactive feature to explore TCTMD’s Top News picks by subspecialists in the field.
Comments